Christine Mundkur

CIK: 0001237264

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

MNKD

MANNKIND CORP

Director

CAH

CARDINAL HEALTH INC

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

MNKD
MANNKIND CORP
May 20, 2026
Award(A)
Restricted Stock Unit
Direct
82.8K shares-
CAH
CARDINAL HEALTH INC
Nov 5, 2025
Award(A)
Direct
1.1K shares-
MNKD
MANNKIND CORP
May 14, 2025
Award(A)
Restricted Stock Unit
Direct
52.9K shares-
CAH
CARDINAL HEALTH INC
Nov 6, 2024
Award(A)
Direct
1.7K shares-

		Type	Shares	Price		Ownership
May 20, 2026	MNKD MANNKIND CORP	Award(A) Restricted Stock Unit	82,781	-	-	Direct
Nov 5, 2025	CAH CARDINAL HEALTH INC	Award(A)	1,067	-	-	Direct
May 14, 2025	MNKD MANNKIND CORP	Award(A) Restricted Stock Unit	52,854	-	-	Direct
Nov 6, 2024	CAH CARDINAL HEALTH INC	Award(A)	1,730	-	$0	Direct

1-4 of 4 transactions

About MUNDKUR CHRISTINE

MUNDKUR CHRISTINE (SEC CIK 0001237264) files insider reports with the SEC as Director of MANNKIND CORP (MNKD) and Director of CARDINAL HEALTH INC (CAH).

Signal8 holds 4 ownership filings by MUNDKUR CHRISTINE, all Form 4s, filed between Nov 7, 2024 and May 22, 2026. Those filings report 4 transactions, from Nov 6, 2024 to May 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MUNDKUR CHRISTINE's filings is in DUBLIN, OH.

Recent filings by MUNDKUR CHRISTINE

May 20, 2026: Grant or award of MNKD derivative securities (Form 4, code A).
Nov 5, 2025: Grant or award of CAH shares (Form 4, code A).
May 14, 2025: Grant or award of MNKD derivative securities (Form 4, code A).
Nov 6, 2024: Grant or award of CAH shares (Form 4, code A).

Other insiders filing for MANNKIND CORP (MNKD)

Binder Steven B., Director
Prentiss Christopher B, Chief Financial Officer
Marasco Dominic, Pres, Endocrine Business Unit
Tross Stuart A, Chief People & Workpl Officer
Castagna Michael, Chief Executive Officer
Singh Sanjay R, EVP Technical Operations

How to read Form 4 transaction codes